Furthermore, analysis of the UALCAN dataset (http://ualcan.path.uab.edu/) demonstrated that YTHDC1 expression was also decreased in different stages of bladder cancer and in patients with lymph node metastasis (Fig. 1i and j). Here, YTHDC1 is linked to urinary bladder carcinoma.